NICHOLAS BORYS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Imunon, Inc.

Filing Date Source Excerpt
2012-04-27 Dr. Nicholas Borys joined Celsion on October 1, 2007 as Vice President and Chief Medical Officer of the Company. No separate director compensation reported.
2022-01-25 Nicholas Borys* Includes 375,424 shares of Common Stock underlying options currently exercisable or exercisable within 60 days of January 14, 2022.

Data sourced from SEC filings. Last updated: 2025-08-30